Trial Profile
LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Acronyms PSO-ABLE
- Sponsors LEO Pharma
- 19 Nov 2020 Results of cost analysis assessing cost per responder, presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
- 28 Jun 2018 Results published in the European Journal of Dermatology
- 19 Jul 2017 Results of post hoc analysis (n=50) published in the British Journal of Dermatology